PRÉNUMBRA - Trademark Details
Status: 700 - Registered
Serial Number
79295828
Registration Number
6504560
Word Mark
PRÉNUMBRA
Status
700 - Registered
Status Date
2021-10-05
Filing Date
2020-08-11
Registration Number
6504560
Registration Date
2021-10-05
Mark Drawing
4000 - Standard character mark
Typeset
Published for Opposition Date
2021-07-20
Attorney Name
Law Office Assigned Location Code
M90
Employee Name
WELLS, KELLEY L
Statements
Goods and Services
Pharmaceuticals for the prevention and treatment of autoimmune, inflammatory and skin diseases or disorders, for the treatment of viral, metabolic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and for the prevention and treatment of genetic diseases and disorders; hemodynamic, vasoactive and anti-oncotic pharmaceuticals; Pharmaceutical drugs for the prevention and treatment of autoimmune, inflammatory and skin diseases or disorders, for the treatment of viral, metabolic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders and for the prevention and treatment of genetic diseases and disorders; hemodynamic, vasoactive and anti-oncotic pharmaceutical drugs; Pharmaceutical preparations for the prevention and treatment of autoimmune, inflammatory and skin diseases or disorders, for the treatment of viral, metabolic, endocrine, musculoskeletal, ophthalmic, cardiovascular, cerebrovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders, for the treatment of vascular anomalies and oedema and for the prevention and treatment of genetic diseases and disorders; hemodynamic, vasoactive and anti-oncotic pharmaceutical preparations; Pharmaceuticals used for cerebrovascular accidents in the nature of strokes; Cardiovascular drug preparations; Cardiovascular pharmaceuticals; cardiovascular pharmaceutical preparations; Cardiovascular medicinal agents for medical purposes; Cardiovascular drugs used in treating shocks; cardiovascular drugs used in myocardial infarctions; cardiovascular drugs used in treating arrhythmias; cardiovascular drugs used in angina pectoris; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular drugs used in treating congestive heart failure (CHF); Pharmaceutical preparations, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide for use in treating skin and skin relating conditions and disorders; Medicated sun tanning preparations for pharmaceutical purposes, preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; Pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; Medicated dermatological preparations; Dermatological pharmaceutical substances; Dermatological pharmaceutical products, namely, preparations for treating or preventing skin disorders; Medicinal creams for the protection of the skin; Medicated skin care creams for medical use for treating or preventing skin disorders; Medicated skin care preparations for medical use; Medicated skin creams and lotions; medicated creams for application after exposure to the sun; pharmaceutical skin lotions; preparations for cleansing the skin for medical use; Chemical and biological preparations, substances, reagents and compounds for the delivery and storage of a wide range of pharmaceuticals which are preferably based on analogues of melanocyte stimulating hormone (MSH), in particular afamelanotide; Afamelanotide hormone in aqueous and gel formulations
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2020-10-19
Primary Code
005
Current Trademark Owners
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Name
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Party Name
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (Limited company).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Mark M. Friedman; Dr. Mark Friedman Ltd
Address
Please log in with your Justia account to see this address.
International Registrations
International Registration Number
1555226
International Registration Date
2020-08-11
International Publication Date
2020-10-15
International Renewal Date
2030-08-11
Auto Protection Date
2022-04-15
International Status
001 - Request for extension of protection established
International Status Date
2020-10-15
Priority Claimed In
True
Priority Claimed Date
2020-02-27
First Refusal In
True
Trademark Events
Event Date | Event Description |
2020-10-15 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
2020-10-19 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2020-10-23 | APPLICATION FILING RECEIPT MAILED |
2020-12-06 | ASSIGNED TO EXAMINER |
2020-12-13 | NON-FINAL ACTION WRITTEN |
2020-12-14 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
2020-12-21 | REFUSAL PROCESSED BY MPU |
2020-12-21 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
2021-01-11 | REFUSAL PROCESSED BY IB |
2021-06-16 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-06-16 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-06-16 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-06-17 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-06-30 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-06-30 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
2021-06-30 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
2021-07-19 | NOTIFICATION PROCESSED BY IB |
2021-07-20 | PUBLISHED FOR OPPOSITION |
2021-07-20 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-10-05 | REGISTERED-PRINCIPAL REGISTER |
2022-01-05 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |